相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis
Samantha Epstein et al.
JOURNAL OF NEUROVIROLOGY (2022)
Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes a ring-shaped hexameric complex
Daniel L. Hurdiss et al.
SCIENCE ADVANCES (2022)
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2
Wenhao Dai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets
Silvia Madeddu et al.
PHARMACEUTICALS (2022)
Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
Magloire Pandoua Nekoua et al.
NATURE REVIEWS ENDOCRINOLOGY (2022)
Enterovirus A71 antivirals: Past, present, and future
Jun Wang et al.
ACTA PHARMACEUTICA SINICA B (2022)
Host Restrictive Factors Are the Emerging Storm Troopers Against Enterovirus: A Mini-Review
Chen Huan et al.
FRONTIERS IN IMMUNOLOGY (2022)
Design of 4-Substituted Sulfonamidobenzoic Acid Derivatives Targeting Coxsackievirus B3
Anton A. Shetnev et al.
LIFE-BASEL (2022)
In-vitro antiviral activity of doxepin hydrochloride against group B coxsackievirus
Yongqi Yang et al.
VIRUS RESEARCH (2022)
The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication
Lucca R. Policastro et al.
VIRUSES-BASEL (2022)
Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication
Patthaya Rattanakomol et al.
SCIENTIFIC REPORTS (2022)
Enterovirus Infection Induces Massive Recruitment of All Isoforms of Small Cellular Arf GTPases to the Replication Organelles
Seyedehmahsa Moghimi et al.
JOURNAL OF VIROLOGY (2021)
In vitro activity of itraconazole against SARS-CoV-2
Ellen Van Damme et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Editorial: Peptides Targeting Protein-Protein Interactions: Methods and Applications
Laura Belvisi et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C
Yuan Fang et al.
JOURNAL OF VIROLOGY (2021)
A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of V-7404 in Healthy Adult Volunteers
Martin K. Kankam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Enteroviruses and coronaviruses: similarities and therapeutic targets
Varpu Marjomaki et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2021)
Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein
Yanmei Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Polyphenols Epigallocatechin Gallate and Resveratrol, and Polyphenol-Functionalized Nanoparticles Prevent Enterovirus Infection through Clustering and Stabilization of the Viruses
Dhanik Reshamwala et al.
PHARMACEUTICS (2021)
Antivirals blocking entry of enteroviruses and therapeutic potential
Mohd Ishtiaq Anasir et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
Luteolin inhibits CVB3 replication through inhibiting inflammation
Shuo Wu et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2020)
N-Acetyl cysteine effectively alleviates Coxsackievirus B-Induced myocarditis through suppressing viral replication and inflammatory response
Yao Wang et al.
ANTIVIRAL RESEARCH (2020)
Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses
Anna Egorova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
Linlin Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Medicinal chemistry strategies toward host targeting antiviral agents
Xingyue Ji et al.
MEDICINAL RESEARCH REVIEWS (2020)
TEMPORARY REMOVAL: DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model (vol 178, 104750, 2020)
Paola Quaranta et al.
ANTIVIRAL RESEARCH (2020)
Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors
Roberto Manganaro et al.
ANTIVIRAL RESEARCH (2020)
Development of broad-spectrum enterovirus antivirals based on quinoline scaffold
Rami Musharrafieh et al.
BIOORGANIC CHEMISTRY (2020)
Therapeutic targets for enterovirus infections
Mira Laajala et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication
Yinxia Zhao et al.
MICROBIAL PATHOGENESIS (2020)
Role of the Guanine Nucleotide Exchange Factor GBF1 in the Replication of RNA Viruses
Jose L. Martinez et al.
VIRUSES-BASEL (2020)
Enterovirus Replication Organelles and Inhibitors of Their Formation
Xinhong Li et al.
FRONTIERS IN MICROBIOLOGY (2020)
Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C
Lisa Bauer et al.
PLOS BIOLOGY (2020)
Glutathione facilitates enterovirus assembly by binding at a druggable pocket
Helen M. E. Duyvesteyn et al.
COMMUNICATIONS BIOLOGY (2020)
Anti-enteroviral activity of new MDL-860 analogues: Synthesis, in vitro/in vivo studies and QSAR analysis
Ivanka Nikolova et al.
BIOORGANIC CHEMISTRY (2019)
Differing activities of oxysterol-binding protein (OSBP) targeting anti-viral compounds
Brett L. Roberts et al.
ANTIVIRAL RESEARCH (2019)
P011 An experimental treatment for enteroviral sepsis
Thomas Wyllie
ARCHIVES OF DISEASE IN CHILDHOOD (2019)
Viral Generated Inter-Organelle Contacts Redirect Lipid Flux for Genome Replication
Orly Laufman et al.
CELL (2019)
A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses
Rana Abdelnabi et al.
PLOS BIOLOGY (2019)
Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner
Lisa Bauer et al.
ACS INFECTIOUS DISEASES (2019)
Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses
Anna Egorova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Transient Compound Treatment Induces a Multigenerational Reduction of Oxysterol-Binding Protein (OSBP) Levels and Prophylactic Antiviral Activity
Brett L. Roberts et al.
ACS CHEMICAL BIOLOGY (2019)
Recent advances on the role of host factors during non-poliovirus enteroviral infections
Collins Oduor Owino et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP)
Lisa Bauer et al.
ANTIVIRAL RESEARCH (2018)
Quinoxaline derivatives as new inhibitors of coxsackievirus B5
Antonio Carta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Investigation of the role of GBF1 in the replication of positive-sense single-stranded RNA viruses
Juliette Ferlin et al.
JOURNAL OF GENERAL VIROLOGY (2018)
Synthesis and Structure-Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication
Yanpeng Xing et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases
Robert Schulz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The life cycle of non-polio enteroviruses and how to target it
Jim Baggen et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Phospholipid synthesis fueled by lipid droplets drives the structural development of poliovirus replication organelles
Ekaterina G. Viktorova et al.
PLOS PATHOGENS (2018)
Picornaviridae-the ever-growing virus family
Roland Zell
ARCHIVES OF VIROLOGY (2018)
Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology
Ivana Mejdrova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response
Nam Nam Cheung et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus infections through innate immunity induced by the inhibition of pyrimidine biosynthesis and nucleotide depletion
Kyungjin Lee et al.
ONCOTARGET (2017)
Direct-acting antivirals and host-targeting strategies to combat enterovirus infections
Lisa Bauer et al.
CURRENT OPINION IN VIROLOGY (2017)
Allosteric Regulation of Phosphatidylinositol 4-Kinase Ill Beta by an Antipicornavirus Compound MDL-860
Minetaro Arita et al.
ACS INFECTIOUS DISEASES (2017)
Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A
Peijun Ren et al.
SCIENTIFIC REPORTS (2017)
Synthesis and anti-enterovirus activity of new analogues of MDL-860
Georgi M. Dobrikov et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
New class of early-stage enterovirus inhibitors with a novel mechanism of action
Yipeng Ma et al.
ANTIVIRAL RESEARCH (2017)
Umifenovir effectively inhibits IL-10 dependent persistent Coxsackie B4 virus infection
Shilin Zhang et al.
ANTIVIRAL RESEARCH (2017)
Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307
Lucian Albulescu et al.
ANTIVIRAL RESEARCH (2017)
Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses
Jun Zuo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C
Rachel Ulferts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Purine analogs as phosphatidylinositol 4-kinase IIIβ inhibitors
Michal Sala et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors
Bo-Kyoung Kim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Coxsackievirus counters the host innate immune response by blocking type III interferon expression
Katharina Lind et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease
Yong Wah Tan et al.
SCIENTIFIC REPORTS (2016)
Discovery of Itraconazole with Broad-Spectrum In Vitro Antienterovirus Activity That Targets Nonstructural Protein 3A
Qianqian Gao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP
Lucian Albulescu et al.
ANTIVIRAL RESEARCH (2015)
Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses
Hyunju Kang et al.
ANTIVIRAL RESEARCH (2015)
Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses
Vadim A. Makarov et al.
CHEMMEDCHEM (2015)
Phosphatidylinositol 4-kinase III beta is the target of oxoglaucine and pachypodol (Ro 09-0179) for their anti-poliovirus activities, and is located at upstream of the target step of brefeldin A
Minetaro Arita et al.
MICROBIOLOGY AND IMMUNOLOGY (2015)
First Use of Investigational Antiviral Drug Pocapavir (V-073) for Treating Neonatal Enteroviral Sepsis
Sanet Torres-Torres et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Replication and Inhibitors of Enteroviruses and Parechoviruses
Lonneke van der Linden et al.
VIRUSES-BASEL (2015)
Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein
Jeroen R. P. M. Strating et al.
CELL REPORTS (2015)
The RNA Template Channel of the RNA-Dependent RNA Polymerase as a Target for Development of Antiviral Therapy of Multiple Genera within a Virus Family
Lonneke van der Linden et al.
PLOS PATHOGENS (2015)
Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases
Lonneke van der Linden et al.
ANTIVIRAL RESEARCH (2014)
An Interaction between Glutathione and the Capsid Is Required for the Morphogenesis of C-Cluster Enteroviruses
Hsin-Chieh Ma et al.
PLOS PATHOGENS (2014)
Binding of Glutathione to Enterovirus Capsids Is Essential for Virion Morphogenesis
Hendrik Jan Thibaut et al.
PLOS PATHOGENS (2014)
Anti-poliovirus activity of protease inhibitor AG-7404, and assessment of in vitro activity in combination with antiviral capsid inhibitor compounds
Eric Rhoden et al.
ANTIVIRAL RESEARCH (2013)
Oxysterol-Binding Protein Family I Is the Target of Minor Enviroxime-Like Compounds
Minetaro Arita et al.
JOURNAL OF VIROLOGY (2013)
Fluoxetine Is a Potent Inhibitor of Coxsackievirus Replication
Jun Zuo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication
Hilde M. van der Schaar et al.
CELL RESEARCH (2012)
Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis
Peter Seizer et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Phosphatidylinositol 4-Kinase III Beta Is a Target of Enviroxime-Like Compounds for Antipoliovirus Activity
Minetaro Arita et al.
JOURNAL OF VIROLOGY (2011)
Differential Effects of the Putative GBF1 Inhibitors Golgicide A and AG1478 on Enterovirus Replication
Lonneke van der Linden et al.
JOURNAL OF VIROLOGY (2010)
Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307
Armando M. De Palma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
GBF1, a Guanine Nucleotide Exchange Factor for Arf, Is Crucial for Coxsackievirus B3 RNA Replication
Kjerstin H. W. Lanke et al.
JOURNAL OF VIROLOGY (2009)
The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C
Armando M. De Palma et al.
JOURNAL OF VIROLOGY (2008)
Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance
Ron Geller et al.
GENES & DEVELOPMENT (2007)
In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease
AK Patick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers
FG Hayden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
分享论文
